Company page

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. is a public company traded under the ticker SYRS in the American market, with a market capitalization of approximately $2.68 billion. The company focuses on developing innovative therapies for cancer and other serious diseases. Syros aims to advance its pipeline of drug candidates to address unmet medical needs in the oncology space.